Drug firm Aurobindo PharmaNSE 1.39 % Tuesday said its arm Helix Healthcare BV has entered into a pact with Shandong Luoxin Pharmaceutical Group Stock Co to establish a JV firm in China to manufacture nebuliser inhaler...
Alembic Pharmaceuticals plans to raise up to Rs 5 bn through issue of NCDs
Drug firm Alembic Pharmaceuticals Thursday said it plans to raise up to Rs 5 billion through the issue of non-convertible debentures (NCDs) on private placement basis. The company’s board of directors Thursday...
Takeda shareholders give nod for $59 billion Shire acquisition
Takeda Pharmaceutical (4502.T) shareholders approved on Wednesday its $59 billion takeover of London-listed Shire (SHP.L), creating a global powerhouse with a stronger drugs pipeline but one that is saddled with massive...
Jubilant Life arm inks pact to acquire Inipharm Inc for around USD 28.5 mn
Drug firm Jubilant Life SciencesNSE 1.01 % Thursday said its subsidiary Drug Discovery and Development Solutions Ltd (DDDSL) Singapore has entered into an agreement to acquire 10 per cent stake in Inipharm Inc USA for...
Sun Pharma to acquire Japan’s Pola Pharma for $1 million for derma products
Sun Pharma on Monday said it would acquire Japan-based Pola Pharma for $1 million to strengthen its presence in dermatology segment across the globe. The firm has entered into a definitive agreement to acquire Pola...
Drug developer Tesaro explores sale: Bloomberg
Cancer drug developer Tesaro Inc (TSRO.O) is exploring a sale and is working with financial advisers after receiving takeover interest, Bloomberg reported on Friday, citing people familiar with the matter. Shares of the...
Cipla’s subsidiary to acquire US-based Avenue Therapeutics for $ 215 million
Drug major CiplaNSE -1.19 % Tuesday said its subsidiary InvaGen Pharmaceuticals Inc has entered into definitive agreements to acquire US-based speciality business firm Avenue Therapeutics for up to USD 215 million...
Aurobindo Pharma to acquire under development product, related assets from Advent for $12.5mn
Drug firm Aurobindo PharmaNSE -2.15 % said Monday its arm Aurobindo Pharma USA Inc has signed a pact to acquire an under-development product and certain related assets from Australian Advent Pharmaceuticals Pty Ltd for...
Natco Pharma to commence Rs 2.5-billion share buyback on November 19
Natco Pharma Limited on Friday announced the share buyback schedule commencing on November 19. Last week, the company board decided to buy back shares for a price of Rs 1,000 per share from the open market by spending a...
Takeda CEO confident of investor backing for $62 billion Shire deal
The boss of Japan’s Takeda Pharmaceutical (4502.T) said on Monday he was confident of securing investor backing for its $62 billion acquisition of London-listed Shire (SHP.L), despite some shareholders’ fears about the...
Novartis to acquire US-based cancer drugmaker Endocyte for $2.1 billion
Novartis AG agreed to buy cancer drugmaker Endocyte for $2.1 billion, or $24 a share, expanding further into the increasingly competitive and lucrative field of oncology. Endocyte, based in the U. S., makes radioactive...
Promius Pharma sells rights of Cloderm cream to EPI Health, LLC: Dr Reddy’s
Dr Reddy’s Laboratories Limited announced on Tuesday that its wholly-owned subsidiary Promius Pharma has sold its rights of Cloderm (Clocortolone pivalate) cream, and its authorised generic to EPI Health, LLC...
